Title Page
Article Outline
Early Clinical Experiences with Daptomycin for the Treatment of Gram-Positive Infections
Guest Editors
Kenneth V.I. Rolston, MD
M.D. Anderson Cancer Center
University of Texas
Houston, Texas
John Segreti, MD
Rush University Medical Center
Chicago, Illinois
This supplement was supported by an educational grant provided by Cubist Pharmaceuticals, Inc., Lexington, Massachusetts. Editorial support was provided by ApotheCom Associates LLC, Wakefield, Massachusetts.
Statement of Peer Review: All supplement manuscripts submitted to The American Journal of Medicine for publication are reviewed by the Guest Editor(s) of the supplement, by an outside peer reviewer who is independent of the supplement project, and by the Journal’s Supplement Editor (who ensures that questions raised in peer review have been addressed appropriately and that the supplement has an educational focus that is of interest to our readership).
Author Disclosure Policy: All authors contributing to supplements in The American Journal of Medicine are required to fully disclose any primary financial relationship with a company that has a direct fiscal or financial interest in the subject matter or products discussed in the submitted manuscripts, or with a company that produces a competing product. These relationships (e.g., ownership of stock or significant honoraria or consulting fees) and any direct support of research by a commercial company must be indicated on the title page of each manuscript. This information will be published in the frontmatter of each supplement.
Editor-in-Chief: Joseph S. Alpert, MD
Editor, Supplements: William H. Frishman, MD
Publishing Director: Pamela Poppalardo
Executive Supplements Editor: Brian Jenkins
Senior Production Editor: Mickey Kramer
Proof/Production Editor: Mary Crowell
PII: S0002-9343(07)00859-5
doi:10.1016/j.amjmed.2007.09.002

